S. P. Yazdankhah and D. A. Caugant, Neisseria meningitidis: an overview of the carriage state, p.438

, J Med Microbiol, vol.53, pp.821-853, 2004.

D. A. Caugant and M. C. Maiden, Meningococcal carriage and disease--population biology and 440 evolution, Vaccine, vol.27, issue.2, pp.64-70, 2009.

N. E. Rosenstein, M. Fischer, and J. W. Tappero, Meningococcal vaccines, vol.15, pp.155-69, 2001.

P. Brandtzaeg and M. Van-deuren, Classification and pathogenesis of meningococcal 444 infections, Methods Mol Biol, vol.799, pp.21-35, 2012.

A. C. Cohn, J. R. Macneil, L. H. Harrison, C. Hatcher, J. Theodore et al., , p.446

K. E. Arnold, J. Baumbach, N. Bennett, A. S. Craig, M. Farley et al.,

A. Lynfield, W. Reingold, K. A. Schaffner, E. R. Shutt, L. W. Zell et al.,

N. E. Stephens and . Messonnier, Changes in Neisseria meningitidis disease epidemiology in the 449

, United States, 1998-2007: implications for prevention of meningococcal disease, Clin Infect, p.450

, Dis, vol.50, issue.2, pp.184-91, 2010.

S. Nadel, Prospects for eradication of meningococcal disease, Arch Dis Child, vol.97, issue.11, pp.993-1001, 2012.

R. Ovstebo, P. Brandtzaeg, B. Brusletto, K. B. Haug, K. Lande et al., , p.454

F. Madhi, C. Levy, A. E. Deghmane, S. Bechet, R. Cohen et al., , p.485

, Therapy in Genotype ST-11 Meningococcal Infections, vol.32, pp.291-486, 2013.

D. Annane, E. Bellissant, P. E. Bollaert, J. Briegel, D. Keh et al., Corticosteroids for 488 treating sepsis, Cochrane Database Syst Rev, issue.12, p.2243, 2015.

M. L. Zarantonelli, M. Szatanik, D. Giorgini, E. Hong, M. Huerre et al.,

M. K. Alonso and . Taha, Transgenic mice expressing human transferrin as a model for 491 meningococcal infection, Infect Immun, vol.75, issue.12, pp.5609-5623, 2007.

D. Perkins-balding, M. Ratliff-griffin, and I. Stojiljkovic, Iron transport systems in Neisseria 493 meningitidis, Microbiol Mol Biol Rev, vol.68, issue.1, pp.154-71, 2004.

M. Levy, A. Antunes, L. Fiette, A. E. Deghmane, and M. K. Taha, Impact of corticosteroids 495 on experimental meningococcal sepsis in mice, Steroids, vol.101, pp.96-102, 2015.

A. E. Deghmane, I. Parent-du-chatelet, M. Szatanik, E. Hong, C. Ruckly et al.,

J. M. Levy-bruhl, M. K. Alonso, and . Taha, Emergence of new virulent Neisseria meningitidis, p.498
URL : https://hal.archives-ouvertes.fr/pasteur-02085474

, serogroup C sequence type 11 isolates in France, J Infect Dis, vol.202, issue.2, pp.247-50, 2010.

T. Guiddir, A. E. Deghmane, D. Giorgini, and M. K. Taha, Lipocalin 2 in cerebrospinal fluid 500 as a marker of acute bacterial meningitis, BMC Infect Dis, vol.14, issue.1, p.276, 2014.

C. Trapnell, B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan et al., , p.502

J. Figueroa, J. Andreoni, and P. Densen, Complement deficiency states and meningococcal 557 disease, Immunol Res, vol.12, issue.3, pp.295-311, 1993.

X. Wang, D. Zhang, M. Sjolinder, Y. Wan, and H. Sjolinder, CD46 accelerates macrophage-559 mediated host susceptibility to meningococcal sepsis in a murine model, Eur J Immunol, vol.47, issue.1, pp.119-130, 2017.

U. Baschant and J. Tuckermann, The role of the glucocorticoid receptor in inflammation and 562 immunity, J Steroid Biochem Mol Biol, vol.120, issue.2-3, pp.69-75, 2010.

J. M. Busillo and J. A. Cidlowski, The five Rs of glucocorticoid action during inflammation: 564 ready, reinforce, repress, resolve, and restore, Trends Endocrinol Metab, vol.24, issue.3, pp.109-128, 2013.

A. Kleiman, S. Hübner, J. M. Rodriguez-parkitna, A. Neumann, S. Hofer et al., , p.566

M. Bauer, W. Schmid, G. Schutz, C. Libert, H. M. Reichardt et al., , p.567

, Glucocorticoid receptor dimerization is required for survival in septic shock via suppression 568 of interleukin-1 in macrophages, FASEB J, vol.26, issue.2, pp.722-731, 2012.

P. J. Murray and T. A. Wynn, Protective and pathogenic functions of macrophage subsets, p.570

, Nat Rev Immunol, vol.11, issue.11, pp.723-760, 2011.

C. Nathan and A. Ding, Nonresolving inflammation, Cell, vol.140, issue.6, pp.871-82, 2010.

H. Patel and D. Davidson, Control of pro-inflammatory cytokine release from human 573 monocytes with the use of an interleukin-10 monoclonal antibody, Methods Mol Biol, p.1172